{
  "methodology": "K-Means clustering with Ahlqvist et al. (2018) subtype classification",
  "features_used": [
    "hba1c",
    "fbs",
    "bmi",
    "triglycerides",
    "ldl",
    "hdl",
    "age"
  ],
  "n_samples": 1063,
  "k_selected": 4,
  "k_optimal_by_silhouette": 2,
  "silhouette_score": 0.1867,
  "k_range_analysis": [
    {
      "k": 2,
      "silhouette": 0.4384,
      "wcss": 5890.35
    },
    {
      "k": 3,
      "silhouette": 0.1815,
      "wcss": 4891.37
    },
    {
      "k": 4,
      "silhouette": 0.1867,
      "wcss": 4298.28
    },
    {
      "k": 5,
      "silhouette": 0.1808,
      "wcss": 3903.53
    },
    {
      "k": 6,
      "silhouette": 0.1784,
      "wcss": 3584.91
    }
  ],
  "cluster_profiles": {
    "SIDD": {
      "label": "SIDD",
      "count": 70,
      "percentage": 6.6,
      "means": {
        "hba1c": 9.53,
        "fbs": 232.61,
        "bmi": 35.82,
        "triglycerides": 163.43,
        "ldl": 119.14,
        "hdl": 48.7,
        "age": 54.97
      },
      "medians": {
        "hba1c": 9.15,
        "fbs": 221.5,
        "bmi": 35.6,
        "triglycerides": 139.0,
        "ldl": 113.0,
        "hdl": 47.5,
        "age": 56.0
      },
      "info": {
        "full_name": "Severe Insulin-Deficient Diabetes",
        "characteristics": "Highest HbA1c, lower BMI, younger onset",
        "clinical_implication": "May need early insulin therapy",
        "risk_level": "HIGH"
      }
    },
    "SIRD": {
      "label": "SIRD",
      "count": 289,
      "percentage": 27.2,
      "means": {
        "hba1c": 5.85,
        "fbs": 106.48,
        "bmi": 30.12,
        "triglycerides": 188.09,
        "ldl": 149.25,
        "hdl": 48.44,
        "age": 55.77
      },
      "medians": {
        "hba1c": 5.8,
        "fbs": 103.0,
        "bmi": 29.5,
        "triglycerides": 174.0,
        "ldl": 148.0,
        "hdl": 48.0,
        "age": 56.0
      },
      "info": {
        "full_name": "Severe Insulin-Resistant Diabetes",
        "characteristics": "High BMI, high TG, low HDL (metabolic syndrome pattern)",
        "clinical_implication": "Responds well to insulin sensitizers (metformin)",
        "risk_level": "HIGH"
      }
    },
    "MOD": {
      "label": "MOD",
      "count": 300,
      "percentage": 28.2,
      "means": {
        "hba1c": 5.93,
        "fbs": 109.42,
        "bmi": 38.28,
        "triglycerides": 103.62,
        "ldl": 111.49,
        "hdl": 52.98,
        "age": 52.43
      },
      "medians": {
        "hba1c": 5.85,
        "fbs": 104.5,
        "bmi": 37.35,
        "triglycerides": 100.0,
        "ldl": 112.0,
        "hdl": 52.0,
        "age": 52.0
      },
      "info": {
        "full_name": "Mild Obesity-Related Diabetes",
        "characteristics": "High BMI (>30), moderate HbA1c elevation",
        "clinical_implication": "Weight management primary intervention",
        "risk_level": "MODERATE"
      }
    },
    "MARD": {
      "label": "MARD",
      "count": 404,
      "percentage": 38.0,
      "means": {
        "hba1c": 5.54,
        "fbs": 98.36,
        "bmi": 25.61,
        "triglycerides": 77.86,
        "ldl": 122.26,
        "hdl": 72.28,
        "age": 54.98
      },
      "medians": {
        "hba1c": 5.5,
        "fbs": 97.0,
        "bmi": 25.35,
        "triglycerides": 75.0,
        "ldl": 121.0,
        "hdl": 71.0,
        "age": 55.0
      },
      "info": {
        "full_name": "Mild Age-Related Diabetes",
        "characteristics": "Older age at diagnosis, mild metabolic dysfunction",
        "clinical_implication": "Conservative management, slower progression",
        "risk_level": "LOW"
      }
    }
  },
  "note": "K=4 selected to match Ahlqvist literature. Silhouette analysis suggested K=2. This may indicate menopausal population-specific clustering patterns."
}